August 28, 2018 Clinical Research/Diagn. Life Science Tools Product Launch

Swift Biosciences Launches Swift Amplicon HS Panels, Enabling Confident Targeted Detection of Low Frequency Variants from Liquid Biopsy Sequencing

(ANN ARBOR, Mich. – Aug. 28, 2018 ) Swift Biosciences today announced early access availability of its Swift Amplicon HS Panels, a new, high-sensitivity targeted amplicon library preparation kit for next-generation sequencing (NGS) of liquid biopsy samples, including cell-free DNA (cfDNA). This addition to Swift’s targeted NGS portfolio facilitates the detection and validation of mutations occurring at... Read more

August 27, 2018 Clinical Research/Diagn.

Enzo Biochem to Acquire New Facility for Manufacturing and Distribution to Advance Its Diagnostic and Therapeutic Growth Strategy

Facility Will Enhance Enzo’s Ability to Produce and Distribute Its Growing Portfolio of Molecular Assays, Immunohistochemistry, Immunoassays and Immuno-oncology Products and Services Anticipates Significant Tax and Other Incentives for Enzo’s Entire Farmingdale New York Campus August 27, 2018 05:30 AM Pacific Daylight Time NEW YORK–(BUSINESS WIRE)–Enzo Biochem, Inc. (NYSE:ENZ), an integrated diagnostic and therapeutics company,... Read more

August 24, 2018 Clinical Research/Diagn. Lab Top-10 M&A, Partnerships

Bruker Announces Agreement to Acquire Majority in Infectious Disease-focused Molecular Diagnostics (MDx) Company Hain Lifescience GmbH

— Bruker’s MALDI Biotyper and IR Biotyper microbiology platforms to be complemented by innovative Hain solutions for molecular diagnostics (MDx) of bacterial and viral infections — Acquisition to expand Bruker’s presence in attractive microbiology and virology infectious disease MDx markets, in support of Bruker’s portfolio transformation — Hain to add expertise in tuberculosis and mycobacteria... Read more

August 21, 2018 Clinical Research/Diagn. Lab Top-10 Life Science Tools M&A, Partnerships Mass Spectrometry

Agena Bioscience Announces Collaboration with PerkinElmer

21 August 2018 Combining LabChip® GX Touch Nucleic Acid Analyzer and MassARRAY® for Optimized Liquid Biopsy Workflow San Diego, CA – Agena Bioscience (Agena) announced today that they have entered into a collaboration with PerkinElmer, incorporating the LabChip® GX Touch™ nucleic acid analyzer for quality assessment and quantitation of DNA in the upfront workflow of Agena’s MassARRAY®system. The... Read more

August 21, 2018 Acad, Gov/Utilities Clinical Research/Diagn. Lab Top-10

Agilent Companion Diagnostic Gains Expanded FDA Approval in Urothelial Carcinoma

Agilent Companion Diagnostic Gains Expanded FDA Approval in Urothelial Carcinoma PD-L1 IHC 22C3 pharmDx Now Approved to Identify Certain Urothelial Carcinoma Patients for Treatment With KEYTRUDA(R) (pembrolizumab) SANTA CLARA, Calif., August 21, 2018 Agilent Technologies Inc. (NYSE: A) today announced that the U.S. Food and Drug Administration (FDA) has approved its Dako PD-L1 IHC 22C3... Read more

August 8, 2018 Clinical Research/Diagn. Product Launch

Bio-Techne Introduces GMP Small Molecules for Stem Cell Therapy Development

 Download as PDF AUGUST 08, 2018 MINNEAPOLIS, Aug. 8, 2018 /PRNewswire/ — Bio-Techne has introduced a new range of Tocris Bioscience-branded stem cell research compounds produced to cGMP standards, which are suitable for use as ancillary materials in the development of stem cell therapies. Bio-Techne has a highly-qualified team who have full control over the... Read more

August 1, 2018 Clinical Research/Diagn. Product Launch

VolitionRx’s First Research Use Only Product Is “On-The-Shelf” Today

ISNES, Belgium, Aug. 1, 2018 /PRNewswire/ — VolitionRx Limited (NYSE AMERICAN: VNRX) (“Volition”) today announced that its first product the “Total Nu.Q™ Assay” research use only (RUO) kit, is ready and available for purchase through Active Motif, its Global Sales and Distribution Partner (https://www.activemotif.com/catalog/1266/NuQ-total-assay). This kit, based on Volition’s proprietary Nucleosomics® technology, is the first in a range of... Read more

August 1, 2018 Cell Analysis Tools Clinical Research/Diagn. Lab Top-10 Product Launch

System enhancements provide laboratories with gold-standard1 accuracy to optimize patient care and reduce the risk of emerging antimicrobial resistance

BREA, CALIF. — (Aug. 1, 2018) — Beckman Coulter announced today commercialization of its DxM MicroScan WalkAway system, a diagnostic solution for bacterial identification and antibiotic susceptibility testing for microbiology laboratories. The DxM MicroScan WalkAway system uses direct minimum inhibitory concentrations (MIC) for detection of antimicrobial resistance, offering greater confidence in results through gold-standard accuracy and the... Read more